Resistance to thyroid hormone is associated with raised energy expenditure, muscle mitochondrial uncoupling, and hyperphagia.

Resistance to thyroid hormone (RTH), a dominantly inherited disorder usually associated with mutations in thyroid hormone receptor beta (THRB), is characterized by elevated levels of circulating thyroid hormones (including thyroxine), failure of feedback suppression of thyrotropin, and variable tissue refractoriness to thyroid hormone action. Raised energy expenditure and hyperphagia are recognized features of hyperthyroidism, but the effects of comparable hyperthyroxinemia in RTH patients are unknown. Here, we show that resting energy expenditure (REE) was substantially increased in adults and children with THRB mutations. Energy intake in RTH subjects was increased by 40%, with marked hyperphagia particularly evident in children. Rates of muscle TCA cycle flux were increased by 75% in adults with RTH, whereas rates of ATP synthesis were unchanged, as determined by 13C/31P magnetic resonance spectroscopy. Mitochondrial coupling index between ATP synthesis and mitochondrial rates of oxidation (as estimated by the ratio of ATP synthesis to TCA cycle flux) was significantly decreased in RTH patients. These data demonstrate that basal mitochondrial substrate oxidation is increased and energy production in the form of ATP synthesis is decreased in the muscle of RTH patients and that resting oxidative phosphorylation is uncoupled in this disorder. Furthermore, these observations suggest that mitochondrial uncoupling in skeletal muscle is a major contributor to increased REE in patients with RTH, due to tissue selective retention of thyroid hormone receptor alpha sensitivity to elevated thyroid hormone levels.

[1]  F. G. Benedict,et al.  A biometric study of basal metabolism in man , 2010 .

[2]  P. Park,et al.  Thyroid hormone-related regulation of gene expression in human fatty liver. , 2009, The Journal of clinical endocrinology and metabolism.

[3]  J. Lazarus,et al.  Augmentation index in resistance to thyroid hormone (RTH) , 2009, Clinical endocrinology.

[4]  Brian W Kim,et al.  Thyroid hormone as a determinant of energy expenditure and the basal metabolic rate. , 2008, Thyroid : official journal of the American Thyroid Association.

[5]  A. Berkenstam,et al.  The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans , 2008, Proceedings of the National Academy of Sciences.

[6]  X. Papademetris,et al.  The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome , 2007, Proceedings of the National Academy of Sciences.

[7]  G. Shulman,et al.  Overexpression of uncoupling protein 3 in skeletal muscle protects against fat-induced insulin resistance. , 2007, The Journal of clinical investigation.

[8]  K. Petersen,et al.  Impaired Mitochondrial Substrate Oxidation in Muscle of Insulin-Resistant Offspring of Type 2 Diabetic Patients , 2007, Diabetes.

[9]  T. Scanlan,et al.  Thyroid hormone receptor beta-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats. , 2007, The Journal of endocrinology.

[10]  Spain,et al.  Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. , 2007, The New England journal of medicine.

[11]  Claudio Cobelli,et al.  Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men , 2006, Proceedings of the National Academy of Sciences.

[12]  R. Evans,et al.  Anatomical Profiling of Nuclear Receptor Expression Reveals a Hierarchical Transcriptional Network , 2006, Cell.

[13]  T. Scanlan,et al.  Thyroid hormone receptor-β-selective agonist GC-24 spares skeletal muscle type I to II fiber shift , 2005, Cell and Tissue Research.

[14]  J. Baxter,et al.  Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: selective actions relative to 3,5,3'-triiodo-L-thyronine. , 2004, Endocrinology.

[15]  K. Petersen,et al.  Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. , 2004, The New England journal of medicine.

[16]  Johan Malm,et al.  Selective thyroid hormone receptor-β activation: A strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Douglas L. Rothman,et al.  Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance , 2003, Science.

[18]  Tim Cheetham,et al.  Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. , 2003, The New England journal of medicine.

[19]  Graham M Lord,et al.  Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. , 2002, The Journal of clinical investigation.

[20]  K. Petersen,et al.  Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. , 2002, Diabetes.

[21]  Vincent Lebon,et al.  The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. , 2002, Diabetes.

[22]  Ash A. Alizadeh,et al.  In vivo regulation of human skeletal muscle gene expression by thyroid hormone. , 2002, Genome research.

[23]  H. Pijl,et al.  Food choice in hyperthyroidism: potential influence of the autonomic nervous system and brain serotonin precursor availability. , 2001, Journal of Clinical Endocrinology and Metabolism.

[24]  K. Petersen,et al.  Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle. , 2001, The Journal of clinical investigation.

[25]  Jullie W Pan,et al.  Regional differences in intramyocellular lipids in humans observed by in vivo 1H-MR spectroscopic imaging. , 2001, Journal of applied physiology.

[26]  S. Dufour,et al.  Assessment of mitochondrial energy coupling in vivo by 13C/31P NMR. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S. Colan,et al.  The Thyroid Hormone Receptor-β Gene Mutation R383H Is Associated with Isolated Central Resistance to Thyroid Hormone , 1999 .

[28]  D. Forrest,et al.  Cardiovascular phenotype and temperature control in mice lacking thyroid hormone receptor-β or both α1 and β. , 1999, American journal of physiology. Heart and circulatory physiology.

[29]  D. Forrest,et al.  Cardiovascular phenotype and temperature control in mice lacking thyroid hormone receptor-beta or both alpha1 and beta. , 1999, The American journal of physiology.

[30]  H. Seo,et al.  Thyroid hormone action on liver, heart, and energy expenditure in thyroid hormone receptor beta-deficient mice. , 1998, Endocrinology.

[31]  Frank Baas,et al.  Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor α1 , 1998, The EMBO journal.

[32]  G. Shulman,et al.  Metabolic Defects in Lean Nondiabetic Offspring of NIDDM Parents: A Cross-Sectional Study , 1997, Diabetes.

[33]  R. Valcavi,et al.  Influence of thyroid status on serum immunoreactive leptin levels. , 1997, The Journal of clinical endocrinology and metabolism.

[34]  L. Hoffer,et al.  Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement. , 1997, The Journal of clinical endocrinology and metabolism.

[35]  C. Mantzoros,et al.  Short-term hyperthyroidism has no effect on leptin levels in man. , 1997, The Journal of clinical endocrinology and metabolism.

[36]  C. Marcocci,et al.  Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-beta receptors? , 1995, The Journal of clinical endocrinology and metabolism.

[37]  K. Petersen,et al.  Triiodothyronine treatment increases substrate cycling between pyruvate carboxylase and malic enzyme in perfused rat liver. , 1995, Metabolism: clinical and experimental.

[38]  J. Benichou,et al.  Genetic and Clinical Features of 42 Kindreds with Resistance to Thyroid Hormone: The National Institutes of Health Prospective Study , 1995, Annals of Internal Medicine.

[39]  D. Molnár,et al.  Measured and predicted resting metabolic rate in obese and nonobese adolescents. , 1995, The Journal of pediatrics.

[40]  M. Brand,et al.  Use of Top-Down Elasticity Analysis to Identify Sites of Thyroid Hormone-Induced Thermogenesis , 1995, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[41]  P. Beck‐Peccoz,et al.  Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor beta gene. , 1994, The Journal of clinical investigation.

[42]  K. Petersen,et al.  Substrate cycling between pyruvate and oxaloacetate in awake normal and 3,3'-5-triiodo-L-thyronine-treated rats. , 1994, The American journal of physiology.

[43]  R. Weiss,et al.  The syndromes of resistance to thyroid hormone. , 1993, Endocrine reviews.

[44]  R. Weiss,et al.  Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor beta gene. Analysis of 15 families. , 1993, The Journal of clinical investigation.

[45]  M. Lazar.  Thyroid hormone receptors: multiple forms, multiple possibilities. , 1993, Endocrine reviews.

[46]  B. Weintraub,et al.  Identification of a novel mutation in the gene encoding the β‐triiodothyronine receptor in a patient with apparent selective pituitary resistance to thyroid hormone , 1993 .

[47]  B. Weintraub,et al.  Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain. , 1991, The Journal of clinical investigation.

[48]  V K Chatterjee,et al.  Thyroid hormone resistance syndrome. Inhibition of normal receptor function by mutant thyroid hormone receptors. , 1991, The Journal of clinical investigation.

[49]  S. Refetoff,et al.  Dominant negative transcriptional regulation by a mutant thyroid hormone receptor-beta in a family with generalized resistance to thyroid hormone. , 1990, Molecular endocrinology.

[50]  E. Ravussin,et al.  Skeletal muscle metabolism is a major determinant of resting energy expenditure. , 1990, The Journal of clinical investigation.

[51]  S. Refetoff,et al.  Sex hormone-binding globulin in the diagnosis of peripheral tissue resistance to thyroid hormone: the value of changes after short term triiodothyronine administration. , 1988, The Journal of clinical endocrinology and metabolism.

[52]  E. Ravussin,et al.  Determinants of 24-hour energy expenditure in man. Methods and results using a respiratory chamber. , 1986, The Journal of clinical investigation.

[53]  M. J. Dauncey,et al.  Analysis of gaseous exchange in open-circuit indirect calorimetry , 1984, Medical and Biological Engineering and Computing.

[54]  D. Befroy,et al.  Assessment of in vivo mitochondrial metabolism by magnetic resonance spectroscopy. , 2009, Methods in enzymology.

[55]  T. Yokoi,et al.  Tissue-specific mRNA expression profiles of human nuclear receptor subfamilies. , 2004, Drug metabolism and pharmacokinetics.

[56]  G. Kahaly,et al.  Cardiac involvement in thyroid hormone resistance. , 2002, The Journal of clinical endocrinology and metabolism.

[57]  S. Colan,et al.  The thyroid hormone receptor-beta gene mutation R383H is associated with isolated central resistance to thyroid hormone. , 1999, The Journal of clinical endocrinology and metabolism.

[58]  L. DiPietro,et al.  Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study , 1999, Diabetologia.

[59]  E. Stopa,et al.  AVP V1 receptor-mediated decrease in Cl- efflux and increase in dark cell number in choroid plexus epithelium. , 1999, The American journal of physiology.

[60]  G. Shulman,et al.  Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. , 1997, Diabetes.

[61]  P. Beck‐Peccoz,et al.  The variable clinical phenotype in thyroid hormone resistance syndrome. , 1994, Thyroid : official journal of the American Thyroid Association.

[62]  B. Weintraub,et al.  Identification of a novel mutation in the gene encoding the beta-triiodothyronine receptor in a patient with apparent selective pituitary resistance to thyroid hormone. , 1993, Clinical endocrinology.

[63]  櫻井 晃洋.  Dominant negative transcriptional regulation by a mutant thyroid hormone receptor-β in a family with generalized resistance to thyroid hormone , 1993 .

[64]  M Elia,et al.  Energy expenditure and fuel selection in biological systems: the theory and practice of calculations based on indirect calorimetry and tracer methods. , 1992, World review of nutrition and dietetics.

[65]  J. Oppenheimer,et al.  Functional relationship of thyroid hormone-induced lipogenesis, lipolysis, and thermogenesis in the rat. , 1991, The Journal of clinical investigation.

[66]  Dietary reference values for food energy and nutrients for the United Kingdom. Report of the Panel on Dietary Reference Values of the Committee on Medical Aspects of Food Policy. , 1991, Reports on health and social subjects.

[67]  Schofield Wn,et al.  Predicting basal metabolic rate, new standards and review of previous work , 1985 .

[68]  W. Schofield.  Predicting basal metabolic rate, new standards and review of previous work. , 1985, Human nutrition. Clinical nutrition.